Lifeboat Foundation

A few weeks into sixth grade, Colman Chadam had to leave school because of his DNA.

The situation, odd as it may sound, played out like this. Colman has genetic markers for cystic fibrosis, and kids with the inherited lung disease can’t be near each other because they’re vulnerable to contagious infections. Two siblings with cystic fibrosis also attended Colman’s middle school in Palo Alto, California in 2012. So Colman was out, even though he didn’t actually have the disease, according to a lawsuit that his parents filed against the school district. The allegation? Genetic discrimination.

Yes, genetic discrimination. Get used to those two words together, because they’re likely to become a lot more common. With DNA tests now cheap and readily available, the number of people getting tests has gone way up—along with the potential for discrimination based on the results. When Colman’s school tried to transfer him based on his genetic status, the lawsuit alleges, the district violated the Americans With Disabilities Act and Colman’s First Amendment right to privacy. “This is the test case,” says the Chadam’s lawyer, Stephen Jaffe.

Read more

Less than a year after scientists in China became the first to genetically modify human embryos, a research team in Britain has been given the green light to perform similar work. It’s a huge moment in biotech history—one that could eventually lead to “designer babies.”

Last September, scientists at London’s Francis Crick Institute asked the U.K’s Human Fertilisation and Embryology Authority (HEFA) for permission to perform gene editing work on human embryos. Their request has now been granted, potentially paving the way for other similar work. Human germline editing is deemed controversial because any baby born through the technique has the potential to pass those genetically modified traits down to the next generation. Advocates of the practice say it could eliminate a host of genetic diseases, while at the same time introducing the possibility of human enhancement.

“The work carried out at the Crick will be for research purposes and will look at the first seven days of a fertilized egg’s development (from a single cell to around 250 cells),” noted the lab in a statement. “The knowledge acquired from the research will be important for understanding how a healthy human embryo develops.” Geneticist Kathy Niakan will be overseeing the work.

Read more

I would need to see more studies on this.

The mixed results of China’s new cancer study.

Read more

https://youtube.com/watch?v=3pjTHDdC3C4

War on drugs has a new friend.

The football-sized robots are designed to work in packs, programmed for various tasks from locating wreckage to detecting contraband through a ship’s hull.

Read more

Interesting & a perplexing viewpoint by this author on “Singularity” and AI in general. First, I believe folks have varying views on the word “Singularity.” This author believes it is when machines become smarter than humans. In my case; I see Singularity is when humans and machines become connected to all things; not necessarily when a machine becomes smarter than myself. Also, the author definitely is not open to exploring all the possibilities around AI; thank goodness all innovators do not have this same mindset.

Human-like robots are popping up everywhere. From the factory floor to product packaging and delivery. From restaurants to the battlefield. From patient care to camel racing. And countless other places. The driverless cars we talked about in this column only a few years ago can be seen on the road today. Our electronic devices are not only talking to us, they’re beginning to understand what we need without even having to ask.

All of this has led to rampant speculation about when the so-called “singularity” is going to happen. When machines become “smarter” than humans. Sorry to disappoint, but the ultimate brain isn’t a future generation of IBM’s Watson or some super-distributed artificial intelligence network like the fictional Skynet portrayed in the Terminator movies.

Continue reading “The coming leap in human intelligence” »

First, this study is very biased and flawed. Secondly, have the tech companies considered all of the resistance that we’re all going to face with the provider and payer communities plus their lobbyists when we try to promote medical AI, nanobots, etc.

I have seen some resistance mounted by some providers, some pharma, etc. against CRISPR. And, I believe this type of resistance is only going to hurt patients as well as many cancer survivors with a genetic predisposition to cancer, and other genetic mutations.

A study of mobile health apps’ impact on health care costs represents a limited but crucial step for assessing digital medicine.

Read more

Would YOU have your body cooled to −15C, spinal cord cut, someone else’s head attached to YOUR body with special bio-glue and stay in an induced coma for 3–4 weeks?

This guy will.
#headtransplant

For more information http://www.desireforlife.org/

Read more

Elon Musk, CEO of Space Exploration Technologies (SpaceX) and Tesla Motors, Inc, was at Startmeup Hong Kong and talked about what he thought were areas of technological opportunity.

At 37 minutes into this video Elon Musk talks about high potential technology like Hyperloop which he currently does not have time to address electric aircraftgenetics is thorny but is our best shot at many tough diseasesbrain computer interfaces at the neuron level has potential for intelligence augmentationNeural Lace was mentioned.

Scientists from China and the US have found a pioneering way to inject a tiny electronic mesh sensor into the brain that fully integrates with cerebral matter and enables computers to monitor brain activity.

Continue reading “Elon Musk identifies electric aircraft, genetics and neuron scale brain computer interfaces as high potential technologies” »

Talk about streamlining and improved efficiencies in clinicals.

Livonia, MI — January 25, 2016 — McKesson Pharmacy Systems & Automation (MPS&A) announced the release of the McKesson Clinical Programs Solution™, a new platform that allows pharmacists to build customized wellness programs and maintain vendor programs for patients with specific medical conditions. The Clinical Programs Solution™ also saves pharmacists time and labor costs by automatically synchronizing the data of patients enrolled in a clinical program with McKesson’s EnterpriseRx® pharmacy management system.

“In today’s increasingly competitive healthcare reimbursement environment, pharmacies are under more pressure than ever to create and manage clinical programs that address patient wellness,” said Emilie Ray, president, McKesson Pharmacy Systems & Automation. “Our Clinical Programs Solution can help meet this challenge by providing pharmacists with a flexible, easy-to-use tool to build and manage clinical services that best suit their patients’ needs and positively impact their pharmacy’s bottom line.”

Read more